360 filings
Page 6 of 18
8-K
9ra47
15 Sep 21
PhaseBio Appoints William D. Humphries to Board of Directors
8:04am
4/A
mwxhnl
3 Sep 21
PhaseBio Pharmaceuticals / Susan Elizabeth Arnold ownership change
4:43pm
4/A
cnddyymqxvofsc
3 Sep 21
PhaseBio Pharmaceuticals / John P Sharp ownership change
4:41pm
4
ejlg ci24gxk4v
30 Aug 21
PhaseBio Pharmaceuticals / Jonathan P Mow ownership change
5:52pm
4
qqmki
19 Aug 21
PhaseBio Pharmaceuticals / Nancy J Hutson ownership change
4:24pm
4
4j033o1 s2v
18 Aug 21
PhaseBio Pharmaceuticals / Clay Thorp ownership change
6:07pm
8-K
0nftfmd
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
a3rrmo
10 Aug 21
PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab
8:03am
SC 13G/A
qphx257wk9hq
10 Aug 21
PhaseBio Pharmaceuticals / WELLINGTON MANAGEMENT ownership change
7:57am
4
juunxj0fvi3dbp20f
4 Aug 21
PhaseBio Pharmaceuticals / John P Sharp ownership change
6:58pm
4
55cgnewq007hrbi5
14 Jul 21
PhaseBio Pharmaceuticals / Susan Elizabeth Arnold ownership change
7:06pm
8-K
01f02d
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
4
qv6 rzpemgcdu
4 Jun 21
PhaseBio Pharmaceuticals / den Broek Richard van ownership change
6:17pm
4
7qwpts5lrottt wmfn
4 Jun 21
PhaseBio Pharmaceuticals / Alex Sapir ownership change
6:14pm
4
1qp9gnn1erb
4 Jun 21
PhaseBio Pharmaceuticals / EDMUND HARRIGAN ownership change
6:08pm
4
x1phbqpp a5dd60z9
4 Jun 21
PhaseBio Pharmaceuticals / Peter Justin Klein ownership change
6:07pm
4
v203apyd3x h2y
4 Jun 21
PhaseBio Pharmaceuticals / Caroline M Loewy ownership change
6:06pm
4
5as9 rasgs3dfq7r
4 Jun 21
PhaseBio Pharmaceuticals / Nancy J Hutson ownership change
6:05pm
4
roy5p
4 Jun 21
PhaseBio Pharmaceuticals / Clay Thorp ownership change
6:03pm